BOSTON (AP) _ Pieris Pharmaceuticals Inc. (PIRS) on Thursday reported a loss of $203,000 in its second quarter.
On a per-share basis, the Boston-based company said it had a loss of less than 1 cent.
The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of 1 cent per share.
The biopharmaceutical company posted revenue of $11.7 million in the period, which also did not meet Street forecasts. Four analysts surveyed by Zacks expected $13.5 million.
Pieris Pharmaceuticals shares have decreased 30 percent since the beginning of the year. The stock has increased slightly more than 2 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PIRS at https://www.zacks.com/ap/PIRS